Juvenile idiopathic arthritisNews & Research
20 curated articles for Juvenile idiopathic arthritis — FDA updates, peer-reviewed research, clinical-trial milestones, and sponsor press releases. Sorted newest-first.
- Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases May 14, 2026
Assessment of Subclinical Atherosclerosis Markers and Their Relationship With Disease Activity in Juvenile Idiopathic Arthritis.
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. Although primarily affecting the joints, the prolonged inflammatory process characteristic of this chronic condition may also contribute to early-onset atherosclerosis. This study aimed to evaluate early ma...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Journal of clinical medicine May 13, 2026
The Intertwining Between Arthritis and Inborn Errors of Immunity.
Immune dysregulation is being increasingly recognized as a prominent feature of a wide range inborn errors of immunity (IEIs) with different molecular backgrounds. Among the manifestations of immune dysregulation, inflammatory arthritis has emerged as an important yet underrecognized complication th...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Arthritis research & therapy May 2, 2026
The gut-joint axis in juvenile idiopathic arthritis.
Juvenile idiopathic arthritis (JIA) is an umbrella term for a group of oligo- and poly-arthritic conditions that develop before 16 years of age. While the exact pathophysiology of JIA is still unknown, both genetic and environmental factors are known to contribute to the development and severity of ...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Arthritis care & research Apr 22, 2026
High Health Care Utilization Preceding Diagnosis With Juvenile Idiopathic Arthritis.
Although early diagnosis improves long-term outcomes, patients with juvenile idiopathic arthritis (JIA) often experience prolonged, circuitous paths to diagnosis. To inform diagnostic improvement, we sought to characterize health care utilization in the year preceding diagnosis. We identified 10,021...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Skeletal radiology Apr 21, 2026
Comprehensive evaluation of juvenile idiopathic arthritis using whole-body MRI: a prospective cross-sectional analysis.
To evaluate the role of whole-body magnetic resonance imaging (WBMRI) using a noninvasive, non-contrast protocol in detecting clinical and subclinical inflammation in pediatric patients with juvenile idiopathic arthritis (JIA) and to assess its impact on treatment decisions. This prospective cross-s...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Journal of stomatology, oral and maxillofacial surgery Apr 21, 2026
Simplified MRI scoring system for TMJ assessment in juvenile idiopathic arthritis.
The temporomandibular joint (TMJ) is a small, yet complex joint. MRI interpretation of TMJ involvement in children with juvenile idiopathic arthritis (JIA) is challenging but essential for the diagnosis and treatment monitoring. We propose a simplified and reproducible MRI scoring system to facilita...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Clinical rheumatology Apr 10, 2026
Clinical characteristics and diagnostic indicators of childhood-onset systemic lupus erythematosus complicated with macrophage activation syndrome.
Analyze the clinical and laboratory characteristics of childhood-onset systemic lupus erythematosus (cSLE) complicated by macrophage activation syndrome (MAS), evaluate the applicability of the 2016 European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology Internati...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- The Journal of rheumatology Apr 2, 2026
Understanding the Current Landscape of Health Disparities Research Among Youth With Juvenile Idiopathic Arthritis.
Understanding the Current Landscape of Health Disparities Research Among Youth With Juvenile Idiopathic Arthritis.
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- ACR open rheumatology Mar 24, 2026
Methotrexate Therapy in Juvenile Idiopathic Arthritis: No Clinically Relevant Pulmonary Impairment but Frequent Transient Liver Enzyme Elevations in a Longitudinal Single-Center Pediatric Cohort of 274 Children Over 30 Years.
Methotrexate (MTX) is a cornerstone in treating juvenile idiopathic arthritis (JIA). The long-term impact of MTX, particularly on pulmonary and liver function, remains a concern. We longitudinally examined the effects of MTX on pulmonary and hepatic function in the largest reported cohort to date. I...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Clinical and experimental rheumatology Mar 17, 2026
Long-term comorbidity patterns in juvenile idiopathic arthritis.
Juvenile idiopathic arthritis (JIA) leads to significant long-term morbidity from articular and extra-articular complications, yet the burden of comorbidities in adults with long-standing disease is not well characterised. This study aimed to determine the prevalence and incidence of key comorbiditi...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- European radiology Mar 6, 2026
ESR Essentials: juvenile idiopathic arthritis; what every radiologist needs to know-practice recommendations by the European Society of Paediatric Radiology.
Juvenile Idiopathic Arthritis (JIA) is a major contributor to chronic diseases, affecting around 1-2 in 1000 children under the age of 16. With modern treatments, the morbidity has been reduced; however, there is increasing evidence that many, if not most, children with JIA will have a chronic disea...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Arthritis research & therapy Mar 6, 2026
Novel advances in juvenile idiopathic arthritis associated uveitis.
Juvenile idiopathic arthritis-associated uveitis (JIA-U) is an important cause of childhood and adult visual impairment. Advances in surveillance approaches and treatment have improved outcomes, yet delayed detection and treatment-refractory disease remain substantial challenges. This review summari...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Arthritis & rheumatology (Hoboken, N.J.) Mar 5, 2026
Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis.
Patients with juvenile idiopathic arthritis (JIA) frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in patients with JIA remains elusive. Plasma samples from 110 untreated patients with activ...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Rheumatology (Oxford, England) Feb 26, 2026
Infant-onset juvenile idiopathic arthritis: a multicentre retrospective study.
Juvenile idiopathic arthritis (JIA) in infants is extremely rare, making diagnosis particularly challenging. This study examines the characteristics of JIA in infancy, including early symptoms, time to diagnosis, JIA categories, treatment approaches and clinical outcomes. Infants diagnosed with JIA ...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry Feb 17, 2026
Clinical characteristics of temporomandibular joint involvement in children with juvenile idiopathic arthritis.
To describe and compare clinical characteristics of TMJ involvement in a sample of children with oligoarthritis and seronegative polyarthritis, and to identify factors increasing the odds for different types of TMJ involvements. A retrospective cross-sectional study of 62 children with oligoarthriti...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Frontiers in pediatrics Feb 16, 2026
An etiopathogenesis of juvenile idiopathic arthritis: the protein-homeostasis-system hypothesis.
The initiation of juvenile idiopathic arthritis (JIA) may be associated with an infection caused by unidentified pathogens. The prevalence or incidence rates of JIA differ markedly among populations. The constituent of microbiota of human species is influenced by age during childhood and differs amo...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Current rheumatology reports Feb 2, 2026
Still's Disease and Autoinflammation: Positioning an Inflammatory Syndrome on the Autoinflammation-Autoimmunity Spectrum.
Still's disease exemplifies systemic inflammatory disorders existing on a continuum between autoinflammation and autoimmunity. This review examines Still's disease through this spectrum lens, integrating recent advances in pathogenesis, clinical heterogeneity, and therapeutic approaches. Emerging me...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Clinical rheumatology Jan 30, 2026
Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registry.
This study aimed to determine whether there are differences in biologic treatment and complications according to subgroups of juvenile idiopathic arthritis (JIA) patients in adulthood. HUR-BIO (Hacettepe University Rheumatology Biologic Registry) has been a single-center biologic disease-modifying a...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Clinical rheumatology Jan 30, 2026
PAFLAR guidelines for oligoarticular juvenile idiopathic arthritis.
To present updated evidence-based recommendations with a range of therapeutic options for children in Africa with oligoarticular juvenile idiopathic arthritis (JIA), adopting the treat to-target approach. This study was conducted by the Paediatric Society of the African League Against Rheumatism (PA...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
- Autoimmunity Jan 24, 2026
Identification of potential diagnostic biomarkers for systemic juvenile idiopathic arthritis by integrative transcriptomic analysis.
The current diagnostic criteria for systemic juvenile idiopathic arthritis (sJIA) lack specificity. Diagnostic biomarkers are in urgent need to help with the early diagnosis of sJIA. Gene expression data of a JIA cohort study from Gene Expression Omnibus (GEO) database was adopted to get hub genes o...
Why it matters: Recent peer-reviewed research on Juvenile idiopathic arthritis that may be relevant for patients and caregivers.
More on Juvenile idiopathic arthritis
Articles aggregated from peer-reviewed journals (PubMed), sponsor press releases, SEC 8-K filings, and FDA announcements. Original-source links are preserved on each article page. Editorial tags (Breaking / Notable / Update) reflect UniteRare's curation-time priority assessment.